Are pan-coronavirus vaccines an achievable goal in providing broad protection against human coronaviruses?

The current achievements in the development of a pan-coronavirus vaccine.

Large-scale SPPS capacity in Braine-l’Alleud starts production – Biotech Investments

PolyPeptide Group / Key word(s): Miscellaneous Large-scale SPPS capacity in Braine-l’Alleud starts production 16.12.2024 / 07:00 CET/CEST Media release Large-scale SPPS capacity in Braine-l’Alleud starts

December 17, 2024

Novo Nordisk gears up for FDA filing with late-phase insulin plus semaglutide data

Novo Nordisk, with data on-hand from a late-stage trial of IcoSema, is preparing for an FDA filing in type 2 diabetes slated for the second

August 13, 2024

Racial discrimination may exacerbate obesity risk in children

Children who experience racial discrimination are more likely to later have a higher body mass index (BMI) and larger waistline, according to a new study

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.